Atlas Trials

Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline)

Clinical trial NCT04947059 · RECRUITING

Trial details

NCT number
NCT04947059
Sponsor
University of Thessaly
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2021-12-14
Primary completion
2025-10-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.